COVID-19 pandemic in Nagaland

Ongoing COVID-19 viral pandemic in Nagaland
COVID-19 pandemic in Nagaland
DiseaseCOVID-19
Virus strainSARS-CoV-2
LocationNagaland
First outbreakWuhan, Hubei
Index caseKohima and Dimapur
Arrival date22 May 2020
Confirmed cases371 (25 June 2020)
Active cases295
Recovered76 (14 June 2020)
Deaths
0
Fatality rate0%
Government website
nagahealth.nagaland.gov.in

The COVID-19 pandemic reached the state of Nagaland on 22 May 2020, with its first case confirmed on 25 May 2020.[1] Officially, Nagaland is the last of the northeastern states after Sikkim to report COVID-19 positive cases.

Timeline

April 2020

On 22 April, a 33-year-old trader based in Dimapur had tested positive in Gauhati Medical College and Hospital (GMCH).

The man had been admitted to a private hospital in Dimapur for treatment but the hospital referred him to the GMCH as the State did not have testing facilities at that point of time. He tested positive hours after he was shifted in an ambulance.

May 2020

  • The first special train carrying over 1469 people, who were stranded in Chennai, reached Dimapur at around 6:20 pm on 22 May. The returnees, mostly students and migrant workers, had started their journey from Chennai on 19 May.[2]
  • On 25 May, the Nagaland state Department of Health and Family Welfare reported the first official cases in the state — three people – two men and a woman – who returned from Chennai on 22 May tested positive for the novel coronavirus.[3]

June 2020

  • As of 26 June, the total number of cases in Nagaland was 371, including 209 active cases and 162 recoveries.[4]

July 2020

On 20 July, total number of cases in Nagaland crossed 1000 mark.[5]

September 2020

  • As of 1 September, the total number of cases in Nagaland was 4003, including 794 active cases and 3191 recoveries. Eight people died from the virus.[4]
  • On 12 September, Nagaland's total covid cases crossed 5000 mark.[6]
  • As of 28 September, the total number of cases was 5957, including 1002 active cases, 4897 recoveries and 12 deaths.[4]

October 2020

  • As of 4 October, the total number of cases in Nagaland is 6552, including 1221 active cases and 5263 recoveries and 12 deaths.[4]

November 2020

  • As of November 13, the total number of cases in Nagaland is 9638, including 727 active cases and 8859 recoveries and 52 deaths.[4]
  • On 17 November, Nagaland passed a grim milestone of 10000 total covid cases.[7]
  • As of November 23, the total number of cases in Nagaland is 10744, including 1442 active cases, 9241 recoveries and 61 deaths.[4]

December 2020

  • As of December 5, the total number of cases in Nagaland is 11305, including 481 active cases, 10759 recoveries and 65 deaths.[4]

January 2021

  • As of January 21, the total number of cases in Nagaland is 11928, including 107 active cases, 11733 recoveries and 88 deaths.[4]

February 2021

  • As of 8 February, the total number of cases in Nagaland was 12009, including 84 active cases, 11837 recoveries and 88 deaths.[4]
  • As of 16 February, the total number of cases was 12039, including 41 active cases, 11908 recoveries and 90 deaths.[4]

March 2021

  • As of 6 March, the total number of cases in Nagaland was 12058, including 15 active cases, 11952 recoveries and 91 deaths.[4]

May 2021

  • As of 26 May, the total number of cases in Nagaland was 14313, including 4923 active cases, 14929 recoveries and 327 deaths.[4]

Sample Testing

Summary of test results
Samples tested 5,945
Positive 371
Positive % 6.24%
Tests per million people [note 1] 300
As of 13 June 2020

Statistics

Total confirmed cases, active cases, recoveries and deaths

  Total confirmed cases      Active Cases      Recoveries      Deaths

Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org.
Linear scale
Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org.
Logarithmic scale

COVID-19 Vaccines with Approval for Emergency or Conditional Usage

Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021.

Covishield

On January 1, 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca's COVID-19 vaccine AZD1222 (marketed as Covishield).[9] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[10] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

Covaxin

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[11]

See also

Notes

  1. ^ Population based on 2019 estimates from National Health Mission [8]

References

  1. ^ Karmakar, Rahul (25 May 2020). "Nagaland reports first COVID 19 case". The Hindu. Retrieved 2020-05-28.
  2. ^ "Shramik special train from Chennai arrives in Dimapur". www.morungexpress.com. 2020-05-22. Retrieved 2020-10-06.
  3. ^ "Nagaland reports 3 coronavirus cases for the first time". www.hindustantimes.com. 25 May 2020. Retrieved 2020-05-28.
  4. ^ a b c d e f g h i j k l "MoHFW-GOI". Ministry of Health and Family Welfare. Retrieved 26 June 2020.
  5. ^ "Nagaland's COVID-19 count surpasses 1,000 with 33 fresh cases". Outlook India. Retrieved 1 September 2020.
  6. ^ "COVID-19 positive cases cross 5,000 mark in Nagaland". News On Air. Retrieved 22 January 2021.
  7. ^ "Nagaland's Covid-19 tally crosses 10,000". Eastern Mirror. 17 November 2020. Retrieved 22 January 2021.
  8. ^ "Report_Population_Projection_2019.pdf" (PDF).
  9. ^ "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 4 January 2021.
  10. ^ "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 4 January 2021.
  11. ^ "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 4 January 2021.

External links

  • v
  • t
  • e
Pre-pandemic
2020
2021
2022
2023 and after
Africa
Northern
Eastern
Southern
Central
Western
Asia
Central/North
East
Mainland China
South
India
By location
Southeast
Malaysia
Philippines
West
Europe
United Kingdom
By location
Eastern
Western Balkans
European Union
EFTA countries
Microstates
North
America
Atlantic
Canada
Caribbean
Countries
British Overseas Territories
Caribbean Netherlands
French West Indies
US insular areas
Central America
United States
responses
By location
Oceania
Australia
New Zealand
South
America
Others
Culture and
entertainment
Arts and
cultural heritage
Education
By country
Sports
By country
By sport
Society
and rights
Social impact
Labor
Human rights
Legal
Minority
Religion
Economic
By country
By industry
Supply and trade
Financial markets
Information
Misinformation
Politics
Political impact
Protests
International relations
Language
Others
Health issues
Medical topics
Testing and
epidemiology
Apps
Prevention
Vaccines
Topics
Authorized
DNA
Inactivated
mRNA
Subunit
Viral vector
Virus-like particles
In trials
Attenuated
  • COVI-VAC (United States)
DNA
Inactivated
RNA
Subunit
Viral vector
Virus-like particles
Deployment
by location
Africa
Asia
Europe
North America
Oceania
South America
Others
Treatment
Monoclonal antibodies
Small molecule antivirals
Specific
General
Institutions
Hospitals and
medical clinics
Mainland China
Others
Organizations
Global
By location
Health
institutes
Pandemic
institutes
Relief funds
People
Medical
professionals
Researchers
Officials
WHO
  • Tedros Adhanom
  • (Director-General of the WHO)
  • Bruce Aylward
  • (Team lead of WHO-China COVID-19 mission)
  • Maria Van Kerkhove
  • (Technical Lead for COVID-19 response)
  • Michael J. Ryan
  • (Executive Director of the WHO Health Emergencies Programme)
By location
Others
Deaths
Data (templates)
Global
Africa
  • Algeria
  • Angola
  • Benin
  • Botswana
  • Burkina Faso
  • Burundi
  • Cameroon
  • Comoros
  • Egypt
  • Eswatini
  • Ethiopia
  • Ghana
    • cases chart
  • Ivory Coast
  • Kenya
  • Libya
  • Malawi
  • Mali
  • Mauritania
  • Mauritius
  • Morocco (including occupied Western Sahara)
  • Mozambique
  • Namibia
  • Nigera
    • cases chart
  • São Tomé and Príncipe
  • Senegal
  • Seychelles
  • Sierra Leone
  • South Africa
    • cases chart
  • South Sudan
  • Sudan
  • Tanzania
  • Togo
  • Tunisia
  • Uganda
  • Zambia
  • Zimbabwe
    • cases chart
Americas
  • Argentina
  • Bolivia
  • Brazil
  • Canada
    • by province
    • vaccinations by province
  • Chile
    • by commune
  • Colombia
  • Costa Rica
    • cases chart
  • Cuba
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Guatemala
  • Haiti
  • Honduras
  • Mexico
    • cases chart
  • Nicaragua
  • Panama
  • Paraguay
  • Peru
  • United States
    • by state
  • Uruguay
  • Venezuela
Asia
  • Afghanistan
  • Armenia
    • Artsakh
  • Azerbaijan
  • Bahrain
  • Bangladesh
    • by division
  • Bhutan
    • cases chart
  • Brunei
  • Cambodia
    • cases chart
    • summary
  • China
    • cases chart
    • confirmed per capita
    • lockdowns
    • by province
    • Hong Kong
    • Macau
  • Cyprus
  • East Timor
  • Egypt
  • Georgia
  • India
  • Indonesia
    • cases chart
  • Iran
    • cases chart
  • Iraq
  • Israel
    • cases chart
  • Japan
    • cases chart
  • Jordan
  • Kazakhstan
  • Kuwait
    • cases chart
  • Kyrgyzstan
  • Laos
  • Lebanon
  • Malaysia
    • cases chart
    • charts
  • Myanmar
    • cases chart
    • summary
  • Nepal
    • cases chart
  • Oman
    • cases chart
  • Pakistan
    • cases chart
  • Philippines
    • cases chart
    • areas of quarantine
    • vaccinations chart
  • Qatar
  • Russia
    • cases chart
    • by federal subject
    • North Asia
  • Saudi Arabia
  • Singapore
  • South Korea
    • cases chart
    • vaccinations charts
  • Sri Lanka
  • Syria
  • Taiwan
    • vaccination charts
  • Tajikistan
  • Thailand
    • cases chart
  • Turkey
    • cases chart
  • United Arab Emirates
    • cases chart
  • Uzbekistan
    • cases chart
  • Vietnam
    • statistics charts
  • Yemen
Europe
  • Albania
  • Austria
    • cases chart
  • Belarus
  • Belgium
    • cases chart
  • Bosnia and Herzegovina
  • Bulgaria
    • cases chart
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
    • cases chart
    • Faroe Islands
  • Estonia
    • cases chart
  • Finland
  • France
    • cases chart
  • Germany
    • cases chart
  • Greece
  • Hungary
  • Iceland
    • cases chart
  • Ireland
    • cases chart
  • Italy
    • cases chart
    • statistics charts
    • vaccinations chart
  • Kosovo
  • Latvia
  • cases chart
  • Lithuania
    • cases chart
  • Luxembourg
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • North Macedonia
  • Norway
    • cases chart
  • Poland
    • cases chart
    • by voivodeship
  • Portugal
    • cases chart
  • Romania
  • cases chart
  • Russia
    • cases chart
    • by federal subject
    • North Asia
  • San Marino
  • Serbia
  • Slovakia
    • cases chart
    • by region
  • Slovenia
    • cases chart
  • Spain
    • cases chart
  • Sweden
    • cases chart
  • Switzerland
    • cases chart
  • Turkey
    • cases chart
  • Ukraine
  • United Kingdom
    • Scotland
      • 2020
      • 2021
    • Gibraltar
    • vaccinations chart
      • daily
      • by nation
  • Vatican City
Oceania
  • Australia
    • by state/territory
  • Fiji
  • French Polynesia
  • New Caledonia
  • New Zealand
  • Papua New Guinea
  • Solomon Islands
Others
  • Cruise ships
    • Diamond Princess
  • v
  • t
  • e
  • Timeline
    • 2020
      • January–May
      • June–December
    • 2021
  • Statistics
    • chart
Topics
Government response
Incidents
Locations
States
Union territories
Legal framework
Agencies and
institutes
Administration
Research
and testing
Public
Private
Vaccines
Others
Officials
Union government
State governments
Agency executives
virus icon COVID-19 portal